Abstract
We synthesized 20 and 21 as conformationally constrained analogues of the dopamine receptor antagonist SKF-83742, as well as analogues 6-9, 16, and 18-22. Although 20 and 21 were inactive, 7, 9, and 19 showed strong binding to D-1, D-2, S-2, and alpha-1 receptors, as well as antipsychotic activity in vivo.
MeSH terms
-
Animals
-
Antipsychotic Agents / chemical synthesis*
-
Antipsychotic Agents / chemistry
-
Antipsychotic Agents / pharmacokinetics
-
Azepines / chemical synthesis*
-
Azepines / chemistry
-
Azepines / pharmacokinetics
-
Benzazepines / chemistry*
-
Brain / metabolism*
-
Dopamine Antagonists / chemical synthesis*
-
Dopamine Antagonists / chemistry
-
Dopamine Antagonists / pharmacokinetics
-
Drug Design
-
Indicators and Reagents
-
Indoles / chemical synthesis*
-
Indoles / chemistry
-
Indoles / pharmacokinetics
-
Molecular Conformation
-
Molecular Structure
-
Rats
-
Receptors, Dopamine / metabolism*
-
Receptors, Dopamine D1 / metabolism
-
Receptors, Dopamine D2 / metabolism
-
Receptors, Serotonin / metabolism*
-
Structure-Activity Relationship
Substances
-
Antipsychotic Agents
-
Azepines
-
Benzazepines
-
Dopamine Antagonists
-
Indicators and Reagents
-
Indoles
-
Receptors, Dopamine
-
Receptors, Dopamine D1
-
Receptors, Dopamine D2
-
Receptors, Serotonin
-
SK&F 83742